Will Pass

News

Rural cancer patients report faster care than urban counterparts

Author:: Will Pass

Publish date: June 18, 2018

In contrast to previous studies, urban patients reported longer delays in care, scoring “Getting Care Quickly” 2.27 points lower than rural patient...

News

Metastatic lung cancer: Pembrolizumab plus chemo prolongs survival

Author:: Will Pass

Publish date: June 5, 2018

Overall survival at 12 months in NSCLC patients treated with pembrolizumab-combination therapy was 69.2%, compared with 49.4% in patients treated w...

News

Checkpoint inhibitors well tolerated by NSCLC patients with preexisting autoimmune disease

Author:: Will Pass

Publish date: May 21, 2018

Flares during checkpoint inhibitor therapy were generally mild, and toxicity rates were only slightly increased in NSCLC patients with AID.